glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Role of the Glutathione Metabolic
Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology Frontiers Metabolic reprogramming in lung cancer and its clinical implication Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



